Back to SCHRODER INVESTMENT MANAGEMENT GROUP SCHRODER INVESTMENT MANAGEMENT GROUP

CORTCORT

Showing 0 of 15 quarters

Position history for SCHRODER INVESTMENT MANAGEMENT GROUPSCHRODER INVESTMENT MANAGEMENT GROUP's holdings in Corcept Therapeutics Incorporated.

No. Schroder Investment Management Group exited its CORT (Corcept Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 96,914 shares worth $2M. Schroder Investment Management Group first reported CORT in Q3 2019 and held it in 14 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used